Similar articles

• Cytotoxic lymphocytes. II. Antagonism and synergism between serum factors and lymphocytes of patients with sarcomas as tested against cultured tumor cells.

  Sinkovics JG, Ahmed N, Hrgovcic MJ, Cabiness JR, Wilbur JR. Sinkovics JG, et al. Tex Rep Biol Med. 1972 Winter;30(4):347-60. Tex Rep Biol Med. 1972. PMID: 4121149 No abstract available.
• Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.

  Catalona WJ, Oldham RK, Djeu JY, Herberman RB, Cannon GB. Catalona WJ, et al. Surg Forum. 1975;26:122-4. Surg Forum. 1975. PMID: 56048 Clinical Trial. No abstract available.
• A comparative study on in vitro cytotoxic reactions of lymphocytes from normal donors and patients with sarcomas to cultured tumor cells.

  Kay HD, Thota H, Sinkovics JG. Kay HD, et al. Clin Immunol Immunopathol. 1976 Mar;5(2):218-34. doi: 10.1016/0090-1229(76)90027-1. Clin Immunol Immunopathol. 1976. PMID: 945141 No abstract available.
• Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.

  Vilien M. Vilien M. Dan Med Bull. 1985 Aug;32(4):199-218. Dan Med Bull. 1985. PMID: 3899526 Review. No abstract available.
• Formation of cytotoxic lymphocytes in mixed leukocyte culture systems: introduction.

  Cerottini JC, MacDonald HR, Brunner KT. Cerottini JC, et al. Transplant Proc. 1973 Dec;5(4):1621-4. Transplant Proc. 1973. PMID: 4130070 Review. No abstract available.